People With Severe Psoriasis Are at Higher Risk of Heart Disease, Researchers Say

Translate to Spanish or other 102 languages!

Experts say people with psoriasis should have regular check-ups with their doctor. Image for illustration purposes
Experts say people with psoriasis should have regular check-ups with their doctor. Image for illustration purposes

Medical News Today

- Advertisement -
  • Researchers report that people with severe psoriasis have a higher risk of heart disease.
  • They note that typical scans for heart disease do not show blockages in the small blood vessels.
  • They say it is important for people with impaired blood flow to aggressively target heart disease risk factors.

In the most extensive study to date to look at coronary blood flow and the link between psoriasis and heart disease, scientists reported a high prevalence of coronary microvascular dysfunction in more than 30% of people with psoriasis who had no symptoms of cardiovascular disease.

Follow the link below to Medical News Today to read the full article:

https://www.medicalnewstoday.com/articles/people-with-severe-psoriasis-are-at-a-higher-risk-fof-heart-disease

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

How Chronic Stress Accelerates Brain Aging

We all feel stressed from time to time, but did you know chronic stress can actually age your brain?

Ultra-Processed Foods Linked to Sharp Rise in Prostate Cancer Risk, Study Finds

Ultra-processed foods (UPFs) account for nearly 60% of adults’ and 70% of children’s energy intake in the United States.

The Overlooked Mental Health Side of Menopause

When it comes to menopause, we often hear about how it can impact a woman’s physical health, but it can affect mental health too. 

Lab-Grown Mini Organs Show Promise in Predicting Breast Cancer Treatment Outcomes

Researchers at UC San Francisco have developed a new method to predict how different types of breast cancer will respond to treatment, using patient data from the I-SPY2 breast cancer trial and rapid testing on lab-grown mini tumors. 
- Advertisement -